Skip to main content
OpenTrials

Clinical trial condition

Uveal Melanoma

Explore clinical trials studying Uveal Melanoma. Study availability and eligibility vary by location and protocol.

204 public trials 37 recruiting studies
Refine in advanced search Browse all conditions

Uveal Melanoma trial results

Active, not recruiting

A Study of APG-115 in as a Monotherapy or Combination With Pembrolizumab in Patients With Metastatic Melanomas or Advanced Solid Tumors

NCT03611868

Conditions
Cutaneous Melanoma, Eye Diseases, Eye Neoplasms, +33 more
Locations
  • University of Arizona Cancer Center Tucson, Arizona, United States
  • Highlands Oncology Rogers, Arkansas, United States
  • UCLA Hematology & Oncology Clinic Los Angeles, California, United States
  • Sarcoma Oncology Research Center Santa Monica, California, United States
View all 21 locations
View Trial Details
Active, not recruiting

Tebentafusp in Molecular Relapsed Disease (MRD) Melanoma

NCT05315258

Conditions
Eye Diseases, Eye Neoplasms, Melanoma, +16 more
Locations
  • Cambridge University Hospitals NHS Foundation Trust (Screening only) Cambridge, United Kingdom
  • The Beatson West of Scotland Cancer Centre Glasgow, United Kingdom
  • The Clatterbridge Cancer Centre Liverpool, United Kingdom
  • University College London Hospital London, United Kingdom
View Trial Details
Active, not recruiting

An Open-Label Expanded Access Study of the Melphalan/Hepatic Delivery System (HDS) in Patients With Hepatic Dominant Ocular Melanoma

NCT05022901

Conditions
Eye Diseases, Eye Neoplasms, Melanoma, +13 more
Locations
  • Stanford Cancer Institute Palo Alto, California, United States
  • Moffitt Cancer Center Tampa, Florida, United States
  • Duke University Medical Center Durham, North Carolina, United States
  • The Ohio State University Columbus, Ohio, United States
View Trial Details
Completed

Percutaneous Hepatic Perfusion in Patients With Hepatic-dominant Ocular Melanoma

NCT02678572

Conditions
Eye Diseases, Eye Neoplasms, Melanoma, +12 more
Locations
  • University of Arizona Tucson, Arizona, United States
  • Stanford University Palo Alto, California, United States
  • Moffitt Cancer Center Tampa, Florida, United States
  • Emory University Atlanta, Georgia, United States
View all 22 locations
View Trial Details

Related conditions